Corcept Therapeutics
1998
FOUNDED
PUBLIC
STATUS
101-200
EMPLOYEES
CORT
STOCK SYMBOL
$13.10
SHARE PRICE
(As of Wednesday Closing)
Description
Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.
Primary Industry
Pharmaceuticals
Stock Exchange
NAS
Primary Office
- 149 Commonwealth Drive
- Menlo Park, CA 94025
- United States
+1 (650) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Corcept Therapeutics’s full profile, request a free trial.
Corcept Therapeutics Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $9.14 - $17.48 | $1.5B | $12.78 | $0.76 | 990K | 114M |
Corcept Therapeutics Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 1,406,603 | 1,347,509 | 1,985,926 | 776,951 |
| Revenue | 285,422 | 251,247 | 159,201 | 81,321 |
| EBITDA | 103,171 | 89,732 | 52,961 | 10,266 |
| Net Income | 86,808 | 75,410 | 129,122 | 8,140 |
| Total Assets | 367,022 | 311,694 | 220,537 | 68,753 |
| Total Debt | 770 | 0 | 0 | 14,664 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Corcept Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Corcept Therapeutics‘s full profile, request access.
Request full access to PitchBookCorcept Therapeutics Competitors (14)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cytokinetics | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000000 | 00000 |
| 000000000 00000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 000000 - 000 | 00000 |
| 0000000 0000000000 | Venture Capital-Backed | San Diego, CA | 0000 | 00000000000 | 0000 | |
| 000000000 00000000 | Corporation | Pasadena, CA | 000 | 00.000 | 0000 | |
| 00000000 000000000 | Formerly VC-backed | Ann Arbor, MI | 00 | 00000 | 00000000000 | 00000 |
Corcept Therapeutics Executive Team (7)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Joseph Belanoff MD | Chief Executive Officer & Founder | ||
| Charles Robb JD | Chief Financial Officer | ||
| Hazel Hunt Ph.D | Director, Research | ||
| Daniel Bradbury | Independent Director |
3 Former Executives
You’re viewing 4 of 7 executives. Get the full list »Corcept Therapeutics Board Members (8)
4 Former Board Members
You’re viewing 4 of 8 board members. Get the full list »